The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Brain Tumor Diagnostics and Therapeutics Market Research Report 2025
Synopsis
The global Brain Tumor Diagnostics and Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Brain Tumor Diagnostics and Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brain Tumor Diagnostics and Therapeutics.
Report Scope
The Brain Tumor Diagnostics and Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Brain Tumor Diagnostics and Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Brain Tumor Diagnostics and Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Novartis
Roche
Merck
Curtana Pharmaceuticals
GE Healthcare
Hitachi Medical
Philips Healthcare
Novocure
AbbVie
Daiichi Sankyo
Genetech
Carthera
EMulate Therapeutics
Segment by Type
Surgery
Radiation Therapy
Targeted Therapy
Chemotherapy
Others
Segment by Application
Hospitals and Cancer Center
Oncology Treatment Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Brain Tumor Diagnostics and Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Brain Tumor Diagnostics and Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Brain Tumor Diagnostics and Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brain Tumor Diagnostics and Therapeutics.
Report Scope
The Brain Tumor Diagnostics and Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Brain Tumor Diagnostics and Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Brain Tumor Diagnostics and Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Novartis
Roche
Merck
Curtana Pharmaceuticals
GE Healthcare
Hitachi Medical
Philips Healthcare
Novocure
AbbVie
Daiichi Sankyo
Genetech
Carthera
EMulate Therapeutics
Segment by Type
Surgery
Radiation Therapy
Targeted Therapy
Chemotherapy
Others
Segment by Application
Hospitals and Cancer Center
Oncology Treatment Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Brain Tumor Diagnostics and Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Brain Tumor Diagnostics and Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Surgery
1.2.3 Radiation Therapy
1.2.4 Targeted Therapy
1.2.5 Chemotherapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Brain Tumor Diagnostics and Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals and Cancer Center
1.3.3 Oncology Treatment Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Brain Tumor Diagnostics and Therapeutics Market Perspective (2019-2030)
2.2 Brain Tumor Diagnostics and Therapeutics Growth Trends by Region
2.2.1 Global Brain Tumor Diagnostics and Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Brain Tumor Diagnostics and Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Brain Tumor Diagnostics and Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Brain Tumor Diagnostics and Therapeutics Market Dynamics
2.3.1 Brain Tumor Diagnostics and Therapeutics Industry Trends
2.3.2 Brain Tumor Diagnostics and Therapeutics Market Drivers
2.3.3 Brain Tumor Diagnostics and Therapeutics Market Challenges
2.3.4 Brain Tumor Diagnostics and Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Brain Tumor Diagnostics and Therapeutics Players by Revenue
3.1.1 Global Top Brain Tumor Diagnostics and Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Brain Tumor Diagnostics and Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Brain Tumor Diagnostics and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Brain Tumor Diagnostics and Therapeutics Revenue
3.4 Global Brain Tumor Diagnostics and Therapeutics Market Concentration Ratio
3.4.1 Global Brain Tumor Diagnostics and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Brain Tumor Diagnostics and Therapeutics Revenue in 2023
3.5 Brain Tumor Diagnostics and Therapeutics Key Players Head office and Area Served
3.6 Key Players Brain Tumor Diagnostics and Therapeutics Product Solution and Service
3.7 Date of Enter into Brain Tumor Diagnostics and Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Brain Tumor Diagnostics and Therapeutics Breakdown Data by Type
4.1 Global Brain Tumor Diagnostics and Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Brain Tumor Diagnostics and Therapeutics Forecasted Market Size by Type (2025-2030)
5 Brain Tumor Diagnostics and Therapeutics Breakdown Data by Application
5.1 Global Brain Tumor Diagnostics and Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Brain Tumor Diagnostics and Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Brain Tumor Diagnostics and Therapeutics Market Size (2019-2030)
6.2 North America Brain Tumor Diagnostics and Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Brain Tumor Diagnostics and Therapeutics Market Size by Country (2019-2024)
6.4 North America Brain Tumor Diagnostics and Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Brain Tumor Diagnostics and Therapeutics Market Size (2019-2030)
7.2 Europe Brain Tumor Diagnostics and Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Brain Tumor Diagnostics and Therapeutics Market Size by Country (2019-2024)
7.4 Europe Brain Tumor Diagnostics and Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Brain Tumor Diagnostics and Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Brain Tumor Diagnostics and Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Brain Tumor Diagnostics and Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Brain Tumor Diagnostics and Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Brain Tumor Diagnostics and Therapeutics Market Size (2019-2030)
9.2 Latin America Brain Tumor Diagnostics and Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Brain Tumor Diagnostics and Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Brain Tumor Diagnostics and Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Brain Tumor Diagnostics and Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Brain Tumor Diagnostics and Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Brain Tumor Diagnostics and Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Brain Tumor Diagnostics and Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Brain Tumor Diagnostics and Therapeutics Introduction
11.1.4 Pfizer Revenue in Brain Tumor Diagnostics and Therapeutics Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Brain Tumor Diagnostics and Therapeutics Introduction
11.2.4 Novartis Revenue in Brain Tumor Diagnostics and Therapeutics Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Brain Tumor Diagnostics and Therapeutics Introduction
11.3.4 Roche Revenue in Brain Tumor Diagnostics and Therapeutics Business (2019-2024)
11.3.5 Roche Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Brain Tumor Diagnostics and Therapeutics Introduction
11.4.4 Merck Revenue in Brain Tumor Diagnostics and Therapeutics Business (2019-2024)
11.4.5 Merck Recent Development
11.5 Curtana Pharmaceuticals
11.5.1 Curtana Pharmaceuticals Company Detail
11.5.2 Curtana Pharmaceuticals Business Overview
11.5.3 Curtana Pharmaceuticals Brain Tumor Diagnostics and Therapeutics Introduction
11.5.4 Curtana Pharmaceuticals Revenue in Brain Tumor Diagnostics and Therapeutics Business (2019-2024)
11.5.5 Curtana Pharmaceuticals Recent Development
11.6 GE Healthcare
11.6.1 GE Healthcare Company Detail
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare Brain Tumor Diagnostics and Therapeutics Introduction
11.6.4 GE Healthcare Revenue in Brain Tumor Diagnostics and Therapeutics Business (2019-2024)
11.6.5 GE Healthcare Recent Development
11.7 Hitachi Medical
11.7.1 Hitachi Medical Company Detail
11.7.2 Hitachi Medical Business Overview
11.7.3 Hitachi Medical Brain Tumor Diagnostics and Therapeutics Introduction
11.7.4 Hitachi Medical Revenue in Brain Tumor Diagnostics and Therapeutics Business (2019-2024)
11.7.5 Hitachi Medical Recent Development
11.8 Philips Healthcare
11.8.1 Philips Healthcare Company Detail
11.8.2 Philips Healthcare Business Overview
11.8.3 Philips Healthcare Brain Tumor Diagnostics and Therapeutics Introduction
11.8.4 Philips Healthcare Revenue in Brain Tumor Diagnostics and Therapeutics Business (2019-2024)
11.8.5 Philips Healthcare Recent Development
11.9 Novocure
11.9.1 Novocure Company Detail
11.9.2 Novocure Business Overview
11.9.3 Novocure Brain Tumor Diagnostics and Therapeutics Introduction
11.9.4 Novocure Revenue in Brain Tumor Diagnostics and Therapeutics Business (2019-2024)
11.9.5 Novocure Recent Development
11.10 AbbVie
11.10.1 AbbVie Company Detail
11.10.2 AbbVie Business Overview
11.10.3 AbbVie Brain Tumor Diagnostics and Therapeutics Introduction
11.10.4 AbbVie Revenue in Brain Tumor Diagnostics and Therapeutics Business (2019-2024)
11.10.5 AbbVie Recent Development
11.11 Daiichi Sankyo
11.11.1 Daiichi Sankyo Company Detail
11.11.2 Daiichi Sankyo Business Overview
11.11.3 Daiichi Sankyo Brain Tumor Diagnostics and Therapeutics Introduction
11.11.4 Daiichi Sankyo Revenue in Brain Tumor Diagnostics and Therapeutics Business (2019-2024)
11.11.5 Daiichi Sankyo Recent Development
11.12 Genetech
11.12.1 Genetech Company Detail
11.12.2 Genetech Business Overview
11.12.3 Genetech Brain Tumor Diagnostics and Therapeutics Introduction
11.12.4 Genetech Revenue in Brain Tumor Diagnostics and Therapeutics Business (2019-2024)
11.12.5 Genetech Recent Development
11.13 Carthera
11.13.1 Carthera Company Detail
11.13.2 Carthera Business Overview
11.13.3 Carthera Brain Tumor Diagnostics and Therapeutics Introduction
11.13.4 Carthera Revenue in Brain Tumor Diagnostics and Therapeutics Business (2019-2024)
11.13.5 Carthera Recent Development
11.14 EMulate Therapeutics
11.14.1 EMulate Therapeutics Company Detail
11.14.2 EMulate Therapeutics Business Overview
11.14.3 EMulate Therapeutics Brain Tumor Diagnostics and Therapeutics Introduction
11.14.4 EMulate Therapeutics Revenue in Brain Tumor Diagnostics and Therapeutics Business (2019-2024)
11.14.5 EMulate Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Brain Tumor Diagnostics and Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Surgery
Table 3. Key Players of Radiation Therapy
Table 4. Key Players of Targeted Therapy
Table 5. Key Players of Chemotherapy
Table 6. Key Players of Others
Table 7. Global Brain Tumor Diagnostics and Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Brain Tumor Diagnostics and Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Brain Tumor Diagnostics and Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Brain Tumor Diagnostics and Therapeutics Market Share by Region (2019-2024)
Table 11. Global Brain Tumor Diagnostics and Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Brain Tumor Diagnostics and Therapeutics Market Share by Region (2025-2030)
Table 13. Brain Tumor Diagnostics and Therapeutics Market Trends
Table 14. Brain Tumor Diagnostics and Therapeutics Market Drivers
Table 15. Brain Tumor Diagnostics and Therapeutics Market Challenges
Table 16. Brain Tumor Diagnostics and Therapeutics Market Restraints
Table 17. Global Brain Tumor Diagnostics and Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Brain Tumor Diagnostics and Therapeutics Market Share by Players (2019-2024)
Table 19. Global Top Brain Tumor Diagnostics and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Tumor Diagnostics and Therapeutics as of 2023)
Table 20. Ranking of Global Top Brain Tumor Diagnostics and Therapeutics Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Brain Tumor Diagnostics and Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Brain Tumor Diagnostics and Therapeutics Product Solution and Service
Table 24. Date of Enter into Brain Tumor Diagnostics and Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Brain Tumor Diagnostics and Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Brain Tumor Diagnostics and Therapeutics Revenue Market Share by Type (2019-2024)
Table 28. Global Brain Tumor Diagnostics and Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Brain Tumor Diagnostics and Therapeutics Revenue Market Share by Type (2025-2030)
Table 30. Global Brain Tumor Diagnostics and Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Brain Tumor Diagnostics and Therapeutics Revenue Market Share by Application (2019-2024)
Table 32. Global Brain Tumor Diagnostics and Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Brain Tumor Diagnostics and Therapeutics Revenue Market Share by Application (2025-2030)
Table 34. North America Brain Tumor Diagnostics and Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Brain Tumor Diagnostics and Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Brain Tumor Diagnostics and Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Brain Tumor Diagnostics and Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Brain Tumor Diagnostics and Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Brain Tumor Diagnostics and Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Brain Tumor Diagnostics and Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Brain Tumor Diagnostics and Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Brain Tumor Diagnostics and Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Brain Tumor Diagnostics and Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Brain Tumor Diagnostics and Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Brain Tumor Diagnostics and Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Brain Tumor Diagnostics and Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Brain Tumor Diagnostics and Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Brain Tumor Diagnostics and Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 49. Pfizer Company Detail
Table 50. Pfizer Business Overview
Table 51. Pfizer Brain Tumor Diagnostics and Therapeutics Product
Table 52. Pfizer Revenue in Brain Tumor Diagnostics and Therapeutics Business (2019-2024) & (US$ Million)
Table 53. Pfizer Recent Development
Table 54. Novartis Company Detail
Table 55. Novartis Business Overview
Table 56. Novartis Brain Tumor Diagnostics and Therapeutics Product
Table 57. Novartis Revenue in Brain Tumor Diagnostics and Therapeutics Business (2019-2024) & (US$ Million)
Table 58. Novartis Recent Development
Table 59. Roche Company Detail
Table 60. Roche Business Overview
Table 61. Roche Brain Tumor Diagnostics and Therapeutics Product
Table 62. Roche Revenue in Brain Tumor Diagnostics and Therapeutics Business (2019-2024) & (US$ Million)
Table 63. Roche Recent Development
Table 64. Merck Company Detail
Table 65. Merck Business Overview
Table 66. Merck Brain Tumor Diagnostics and Therapeutics Product
Table 67. Merck Revenue in Brain Tumor Diagnostics and Therapeutics Business (2019-2024) & (US$ Million)
Table 68. Merck Recent Development
Table 69. Curtana Pharmaceuticals Company Detail
Table 70. Curtana Pharmaceuticals Business Overview
Table 71. Curtana Pharmaceuticals Brain Tumor Diagnostics and Therapeutics Product
Table 72. Curtana Pharmaceuticals Revenue in Brain Tumor Diagnostics and Therapeutics Business (2019-2024) & (US$ Million)
Table 73. Curtana Pharmaceuticals Recent Development
Table 74. GE Healthcare Company Detail
Table 75. GE Healthcare Business Overview
Table 76. GE Healthcare Brain Tumor Diagnostics and Therapeutics Product
Table 77. GE Healthcare Revenue in Brain Tumor Diagnostics and Therapeutics Business (2019-2024) & (US$ Million)
Table 78. GE Healthcare Recent Development
Table 79. Hitachi Medical Company Detail
Table 80. Hitachi Medical Business Overview
Table 81. Hitachi Medical Brain Tumor Diagnostics and Therapeutics Product
Table 82. Hitachi Medical Revenue in Brain Tumor Diagnostics and Therapeutics Business (2019-2024) & (US$ Million)
Table 83. Hitachi Medical Recent Development
Table 84. Philips Healthcare Company Detail
Table 85. Philips Healthcare Business Overview
Table 86. Philips Healthcare Brain Tumor Diagnostics and Therapeutics Product
Table 87. Philips Healthcare Revenue in Brain Tumor Diagnostics and Therapeutics Business (2019-2024) & (US$ Million)
Table 88. Philips Healthcare Recent Development
Table 89. Novocure Company Detail
Table 90. Novocure Business Overview
Table 91. Novocure Brain Tumor Diagnostics and Therapeutics Product
Table 92. Novocure Revenue in Brain Tumor Diagnostics and Therapeutics Business (2019-2024) & (US$ Million)
Table 93. Novocure Recent Development
Table 94. AbbVie Company Detail
Table 95. AbbVie Business Overview
Table 96. AbbVie Brain Tumor Diagnostics and Therapeutics Product
Table 97. AbbVie Revenue in Brain Tumor Diagnostics and Therapeutics Business (2019-2024) & (US$ Million)
Table 98. AbbVie Recent Development
Table 99. Daiichi Sankyo Company Detail
Table 100. Daiichi Sankyo Business Overview
Table 101. Daiichi Sankyo Brain Tumor Diagnostics and Therapeutics Product
Table 102. Daiichi Sankyo Revenue in Brain Tumor Diagnostics and Therapeutics Business (2019-2024) & (US$ Million)
Table 103. Daiichi Sankyo Recent Development
Table 104. Genetech Company Detail
Table 105. Genetech Business Overview
Table 106. Genetech Brain Tumor Diagnostics and Therapeutics Product
Table 107. Genetech Revenue in Brain Tumor Diagnostics and Therapeutics Business (2019-2024) & (US$ Million)
Table 108. Genetech Recent Development
Table 109. Carthera Company Detail
Table 110. Carthera Business Overview
Table 111. Carthera Brain Tumor Diagnostics and Therapeutics Product
Table 112. Carthera Revenue in Brain Tumor Diagnostics and Therapeutics Business (2019-2024) & (US$ Million)
Table 113. Carthera Recent Development
Table 114. EMulate Therapeutics Company Detail
Table 115. EMulate Therapeutics Business Overview
Table 116. EMulate Therapeutics Brain Tumor Diagnostics and Therapeutics Product
Table 117. EMulate Therapeutics Revenue in Brain Tumor Diagnostics and Therapeutics Business (2019-2024) & (US$ Million)
Table 118. EMulate Therapeutics Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Brain Tumor Diagnostics and Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Brain Tumor Diagnostics and Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Surgery Features
Figure 4. Radiation Therapy Features
Figure 5. Targeted Therapy Features
Figure 6. Chemotherapy Features
Figure 7. Others Features
Figure 8. Global Brain Tumor Diagnostics and Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Brain Tumor Diagnostics and Therapeutics Market Share by Application: 2023 VS 2030
Figure 10. Hospitals and Cancer Center Case Studies
Figure 11. Oncology Treatment Centers Case Studies
Figure 12. Others Case Studies
Figure 13. Brain Tumor Diagnostics and Therapeutics Report Years Considered
Figure 14. Global Brain Tumor Diagnostics and Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Brain Tumor Diagnostics and Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Brain Tumor Diagnostics and Therapeutics Market Share by Region: 2023 VS 2030
Figure 17. Global Brain Tumor Diagnostics and Therapeutics Market Share by Players in 2023
Figure 18. Global Top Brain Tumor Diagnostics and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Tumor Diagnostics and Therapeutics as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Brain Tumor Diagnostics and Therapeutics Revenue in 2023
Figure 20. North America Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Brain Tumor Diagnostics and Therapeutics Market Share by Country (2019-2030)
Figure 22. United States Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Brain Tumor Diagnostics and Therapeutics Market Share by Country (2019-2030)
Figure 26. Germany Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Brain Tumor Diagnostics and Therapeutics Market Share by Region (2019-2030)
Figure 34. China Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Brain Tumor Diagnostics and Therapeutics Market Share by Country (2019-2030)
Figure 42. Mexico Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Brain Tumor Diagnostics and Therapeutics Market Share by Country (2019-2030)
Figure 46. Turkey Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Brain Tumor Diagnostics and Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Pfizer Revenue Growth Rate in Brain Tumor Diagnostics and Therapeutics Business (2019-2024)
Figure 49. Novartis Revenue Growth Rate in Brain Tumor Diagnostics and Therapeutics Business (2019-2024)
Figure 50. Roche Revenue Growth Rate in Brain Tumor Diagnostics and Therapeutics Business (2019-2024)
Figure 51. Merck Revenue Growth Rate in Brain Tumor Diagnostics and Therapeutics Business (2019-2024)
Figure 52. Curtana Pharmaceuticals Revenue Growth Rate in Brain Tumor Diagnostics and Therapeutics Business (2019-2024)
Figure 53. GE Healthcare Revenue Growth Rate in Brain Tumor Diagnostics and Therapeutics Business (2019-2024)
Figure 54. Hitachi Medical Revenue Growth Rate in Brain Tumor Diagnostics and Therapeutics Business (2019-2024)
Figure 55. Philips Healthcare Revenue Growth Rate in Brain Tumor Diagnostics and Therapeutics Business (2019-2024)
Figure 56. Novocure Revenue Growth Rate in Brain Tumor Diagnostics and Therapeutics Business (2019-2024)
Figure 57. AbbVie Revenue Growth Rate in Brain Tumor Diagnostics and Therapeutics Business (2019-2024)
Figure 58. Daiichi Sankyo Revenue Growth Rate in Brain Tumor Diagnostics and Therapeutics Business (2019-2024)
Figure 59. Genetech Revenue Growth Rate in Brain Tumor Diagnostics and Therapeutics Business (2019-2024)
Figure 60. Carthera Revenue Growth Rate in Brain Tumor Diagnostics and Therapeutics Business (2019-2024)
Figure 61. EMulate Therapeutics Revenue Growth Rate in Brain Tumor Diagnostics and Therapeutics Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
